Nexgel (NXGL) Cash & Equivalents (2019 - 2025)

Nexgel (NXGL) has 7 years of Cash & Equivalents data on file, last reported at $1.1 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 41.45% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (down 41.45% YoY), and the FY2025 full-year result was $1.1 million, down 41.45% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $1.1 million, up from $938000.0 in the prior quarter.
• Across five years, Cash & Equivalents topped out at $13.4 million in Q4 2021 and bottomed at $382000.0 in Q2 2021.
• The 5-year median for Cash & Equivalents is $1.2 million (2021), against an average of $2.7 million.
• The widest annual swing landed in 2021, when Cash & Equivalents soared 41618.75%; it then slumped 92.52% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $13.4 million in 2021, then sank by 91.75% to $1.1 million in 2022, then soared by 145.23% to $2.7 million in 2023, then sank by 33.07% to $1.8 million in 2024, then tumbled by 41.45% to $1.1 million in 2025.
• The last three Cash & Equivalents figures came in at $1.1 million (Q4 2025), $938000.0 (Q3 2025), and $725000.0 (Q2 2025), per Business Quant data.

Peer Comparison